(4-((2-((tert-Butoxycarbonyl)amino)ethyl)carbamoyl)-phenyl)boronic acid, 95.0%, 25g

6-Bromo-8-methyl-[1,2,4]triazolo[4,3-a]pyridine, 98%, 25g

3-Fluoro-5-iodopyridin-4-amine, 97%, 250mg

Octadecan-1-amine, 85.0%, 100g

2-([1,1'-Biphenyl]-4-yl)-1-phenylethanone, 95.0%, 250mg

(4-Cyclobutylphenyl)methanol, 98%, 10g

3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-6,7-DIHYDRO-4H-PYRAZOLO[5,1-C][1,4]OXAZINE, 95.0%, 100mg

Anti-6xHis Monoclonal Antibody (6A12) HRP Conjugate1vial

(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)methanamine, 97%, 250mg

Sample reservoir Liqui, 150 ml, PP, 1 piece

Methyl Linoleate [Standard Material for GC]>98.0%(GC)1g

1-(4-Bromophenyl)-2-hydroxyethanone, 95%, 25g

methyl 3-(4-formyl-3,5-dimethyl-1H-pyrazol-1-yl)propanoate, 1g